Sprinklr Announces Second Quarter Fiscal 2026 Results

Go back to Sprinklr Announces Second Quarter Fiscal 2026 Results
Cardium Therapeutics, Inc. (NYSE: CXM) Delayed: 7.60 -0.61 (7.43%)
Previous Close $8.21    52 Week High $1.44 
Open $8.08    52 Week Low $0.06 
Day High $8.18    P/E N/A 
Day Low $7.55    EPS $-1.24 
Volume 12,007,080